Medical Devices industry M&A deals total $7.4bn in US in April 2021

Total medical devices industry M&A deals worth $7.4bn were announced in the US in April 2021, with $5bn merger of CA Healthcare Acquisition and LumiraDx being the sector’s biggest investment, according to GlobalData’s deals database.

The value marked an increase of 232.3% over the previous month of $2.23bn and a rise of 2.1% when compared with the last 12-month average of $7.26bn.

The US held an 80.81% share of the global medical devices industry M&A deal value that totalled $9.17bn in April 2021.

In terms of M&A deal activity, the US recorded 23 deals during April 2021, marking a flat growth over the previous month and a flat growth over the 12-month average.

US medical devices industry M&A deals in April 2021: Top deals

The top five medical devices industry M&A deals accounted for 98.4% of the overall value during April 2021.

The combined value of the top five medical devices M&A deals stood at $7.29bn, against the overall value of $7.4bn recorded for the month.

The top five medical devices industry M&A deals of April 2021 tracked by GlobalData were:

1) The $5bn merger of CA Healthcare Acquisition and LumiraDx

2) The $1.8bn acquisition of Luminex by DiaSorin

3) InVitae’ $200m acquisition of Genosity

4) The $187m acquisition of Better Therapeutics by Mountain Crest AcquisitionII

5) The merger of D8 and Vicarious Surgical for $102.15m.

Source: https://www.medicaldevice-network.com/deals-analysis/medical-devices-industry-ma-deals-total-7-4bn-in-us-in-april-2021/